Charles River Laboratories International News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

05.12.24	Charles River Introduces Global Biotech Incubator Program (Businesswire)
02.12.24	Charles River Laboratories to Present at Evercore ISI Investor Conference (Businesswire)
06.11.24	Charles River Laboratories Updates 2024 Guidance - Update (RTTNews)
06.11.24	Charles River Laboratories International Inc. Q3 Profit Decreases, But Beats Estimates (RTTNews)
17.10.24	Charles River Launches New Retrogenix® Non-Human Protein Library (Businesswire)
16.10.24	Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call (Businesswire)
03.10.24	Charles River Provides Translational Expertise at Neuroscience 2024 (Businesswire)
02.10.24	Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease (Businesswire)
17.09.24	Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research (Businesswire)
04.09.24	Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience (Businesswire)
03.09.24	Charles River Laboratories to Present at Baird and Morgan Stanley Conferences (Businesswire)
07.08.24	Charles River Laboratories Slashes FY24 Outlook - Update (RTTNews)
07.08.24	Charles River Laboratories International Inc. Q2 Profit Decreases, But Beats Estimates (RTTNews)
30.07.24	Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development (Businesswire)
24.07.24	Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery (Businesswire)
16.07.24	Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call (Businesswire)
08.07.24	Charles River to Perform Plasmid Manufacturing for AAVantgarde (Businesswire)
25.06.24	Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus (Businesswire)
17.06.24	Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy (Businesswire)
11.06.24	Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives (Businesswire)
06.06.24	Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville (Businesswire)
04.06.24	Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research (Businesswire)
03.06.24	Charles River Laboratories to Present at William Blair and Jefferies Conferences (Businesswire)
30.05.24	Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development (Businesswire)
09.05.24	Charles River Laboratories Reaffirms FY24 Outlook; Q1 Results Top Estimates (RTTNews)
02.05.24	Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP (Businesswire)
22.04.24	Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally (Businesswire)
16.04.24	Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing (Businesswire)
12.04.24	Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call (Businesswire)
11.04.24	Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology (Businesswire)
09.04.24	Charles River To Collaborate With Axovia Therapeutics - Quick Facts (RTTNews)
09.04.24	Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics (Businesswire)
04.04.24	Charles River to Perform Plasmid Production for Ship of Theseus (Businesswire)
04.04.24	Charles River to Perform Plasmid Production for Ship of Theseus (Businesswire)
01.04.24	Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024 (Businesswire)
27.03.24	Charles River Laboratories Publishes 2023 Corporate Citizenship Report (Businesswire)
21.03.24	Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine (Businesswire)
14.03.24	Charles River, Navega Therapeutics Collaborates For Comprehensive Gene Therapy Manufacturing (RTTNews)
14.03.24	Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration (Businesswire)
12.03.24	Charles River Laboratories to Present at Barclays Global Healthcare Conference (Businesswire)
04.03.24	DURECT Inks Co-marketing And Collaboration Deal With Charles River For ALZET Product Line (RTTNews)
21.02.24	Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing (Businesswire)
20.02.24	Charles River Teams Up With Pluristyx For Stem Cell Research (RTTNews)
20.02.24	Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells (Businesswire)
14.02.24	Charles River Laboratories Q4 Results, Outlook Above Street View; Shares UP In Pre-market (RTTNews)
29.01.24	Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test (Businesswire)
24.01.24	Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors (Businesswire)
23.01.24	Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call (Businesswire)
16.01.24	Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing (Businesswire)
08.01.24	Charles River Laboratories to Present at J.P. Morgan Healthcare Conference (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

17.12.24		Börse New York in Rot: S&P 500 startet mit Verlusten
13.11.24		Mittwochshandel in New York: S&P 500 bewegt schlussendlich im Plus
13.11.24		Handel in New York: S&P 500-Anleger greifen nachmittags zu
13.11.24		Aufschläge in New York: S&P 500 am Mittwochmittag im Plus
10.10.24		Anleger in New York halten sich zurück: S&P 500 fällt am Mittag zurück
25.09.24		Schwache Performance in New York: So entwickelt sich der S&P 500 am Mittwochmittag
12.08.24		Montagshandel in New York: S&P 500 beginnt die Montagssitzung in der Verlustzone
07.08.24		Handel in New York: S&P 500 fällt letztendlich zurück

17.12.24

Börse New York in Rot: S&P 500 startet mit Verlusten

13.11.24

Mittwochshandel in New York: S&P 500 bewegt schlussendlich im Plus

13.11.24

Handel in New York: S&P 500-Anleger greifen nachmittags zu

13.11.24

Aufschläge in New York: S&P 500 am Mittwochmittag im Plus

10.10.24

Anleger in New York halten sich zurück: S&P 500 fällt am Mittag zurück

25.09.24

Schwache Performance in New York: So entwickelt sich der S&P 500 am Mittwochmittag